# Fractyl Health Inc. (GUTS)

Source: https://www.quantisnow.com/company/GUTS
Generated: 2026-11-18T14:04:13.267Z

- Ticker: GUTS
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- IPO year: 2024
- SEC CIK: 0001572616

## Latest GUTS news and filings

- 2026-11-13 22:04 UTC [SEC Schedule 13G] [Amendment: SEC Form SCHEDULE 13G/A filed by Fractyl Health Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-fractyl-health-inc-6791335)
- 2026-11-12 21:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Fractyl Health Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-fractyl-health-inc-6787785)
- 2026-11-12 21:05 UTC [SEC Form 8-K] [Fractyl Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/fractyl-health-inc-filed-sec-form-8-k-results-of-operations-6787756)
- 2026-11-12 21:05 UTC [Earnings] [Fractyl Health Reports Third Quarter 2026 Financial Results and Business Updates](https://www.quantisnow.com/insight/fractyl-health-reports-third-quarter-2026-financial-results-and-business-6787683)
- 2026-11-06 22:00 UTC [SEC Form 3] [SEC Form 3 filed by new insider Wartell Michael J.](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-wartell-michael-j-6779440)
- 2026-11-06 21:30 UTC [SEC Form 8-K] [Fractyl Health Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/fractyl-health-inc-filed-sec-form-8-k-leadership-update-financial-6779217)
- 2026-11-06 12:00 UTC [Earnings Date] [Fractyl Health to Report Third Quarter 2026 Financial Results and Provide Business Updates on November 12, 2026](https://www.quantisnow.com/insight/fractyl-health-to-report-third-quarter-2026-financial-results-and-6777873)
- 2026-10-30 11:00 UTC [Fractyl Health Strengthens Revita Patent Portfolio as It Advances Toward FDA Submission and Potential Commercialization](https://www.quantisnow.com/insight/fractyl-health-strengthens-revita-patent-portfolio-as-it-advances-toward-6764443)
- 2026-10-29 11:00 UTC [Fractyl Health Announces Market Research Highlighting Substantial Patient Interest in a One-Time Procedural Approach to Post-GLP-1 Weight Maintenance](https://www.quantisnow.com/insight/fractyl-health-announces-market-research-highlighting-substantial-patient-interest-in-6762327)
- 2026-10-22 11:01 UTC [SEC Form 8-K] [SEC Form 8-K filed by Fractyl Health Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-fractyl-health-inc-6754322)
- 2026-10-22 11:00 UTC [Fractyl Health Sharpens Focus on Revita Following Positive Pivotal Results, Advancing Toward Planned FDA De Novo Submission in Post-GLP-1 Weight Maintenance](https://www.quantisnow.com/insight/fractyl-health-sharpens-focus-on-revita-following-positive-pivotal-results-6754270)
- 2026-10-19 23:18 UTC [INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Fractyl Health, Inc. to Contact Law Firm](https://www.quantisnow.com/insight/investor-action-notice-moore-law-pllc-encourages-investors-in-fractyl-6751110)
- 2026-10-16 14:20 UTC [Market Insight] [GUTS UPCOMING DEADLINE: Levi & Korsinsky Alerts Fractyl Health, Inc. Stockholders of Securities Class Action - Contact the Firm](https://www.quantisnow.com/insight/guts-upcoming-deadline-levi-korsinsky-alerts-fractyl-health-inc-stockholders-6748910)
- 2026-10-16 11:01 UTC [SEC Form 8-K] [SEC Form 8-K filed by Fractyl Health Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-fractyl-health-inc-6748651)
- 2026-10-16 11:00 UTC [Fractyl Health's Revita Meets Six-Month Co-Primary Endpoint in Ongoing REMAIN-1 Pivotal Study, With Highly Statistically Significant Reduction in Weight Regain After GLP-1 Discontinuation](https://www.quantisnow.com/insight/fractyl-healths-revita-meets-six-month-co-primary-endpoint-in-ongoing-remain-1-6748632)
- 2026-10-09 14:30 UTC [Market Insight] [GUTS Shareholder Alert: Fractyl Health, Inc. Securities Class Action Lawsuit - Investors Should Contact Levi & Korsinsky](https://www.quantisnow.com/insight/guts-shareholder-alert-fractyl-health-inc-securities-class-action-lawsuit-6742612)
- 2026-10-02 15:05 UTC [Market Insight] [GUTS DEADLINE: Levi & Korsinsky Reminds Fractyl Health, Inc. Investors of Upcoming Securities Class Action Deadline](https://www.quantisnow.com/insight/guts-deadline-levi-korsinsky-reminds-fractyl-health-inc-investors-of-6733841)
- 2026-10-01 10:30 UTC [SEC Form 8-K] [Fractyl Health Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/fractyl-health-inc-filed-sec-form-8-k-amendments-to-articles-6731268)
- 2026-09-24 20:15 UTC [SEC Form 8-K] [Fractyl Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/fractyl-health-inc-filed-sec-form-8-k-submission-of-matters-6725459)
- 2026-09-16 20:05 UTC [Insider Buy] [Director Bradley William bought $39,903 worth of shares (64,516 units at $0.62), increasing direct ownership by 76% to 149,138 units (SEC Form 4)](https://www.quantisnow.com/insight/director-bradley-william-bought-39903-worth-of-shares-64516-units-6717454)
- 2026-09-11 20:15 UTC [SEC Form 8-K] [Fractyl Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/fractyl-health-inc-filed-sec-form-8-k-notice-of-delisting-6713034)
- 2026-09-09 11:00 UTC [Conference Announcement] [Fractyl Health to Participate in Upcoming September Investor Conferences](https://www.quantisnow.com/insight/fractyl-health-to-participate-in-upcoming-september-investor-conferences-6709150)
- 2026-08-24 20:10 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Fractyl Health Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-fractyl-health-inc-6692715)
- 2026-08-20 11:00 UTC [Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance](https://www.quantisnow.com/insight/fractyl-health-to-host-virtual-commercial-strategy-day-on-tuesday-6689309)
- 2026-08-10 20:05 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Fractyl Health Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-fractyl-health-inc-6673616)
- 2026-08-10 20:05 UTC [SEC Form 8-K] [Fractyl Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/fractyl-health-inc-filed-sec-form-8-k-results-of-operations-6673591)
- 2026-08-10 20:05 UTC [Earnings Date] [Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates](https://www.quantisnow.com/insight/fractyl-health-reports-second-quarter-2026-financial-results-and-business-6673510)
- 2026-08-03 20:05 UTC [Earnings Date] [Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026](https://www.quantisnow.com/insight/fractyl-health-to-report-second-quarter-2026-financial-results-and-6659583)
- 2026-07-22 20:01 UTC [Earnings Date] [Fractyl Health to Participate in Upcoming Investor Events](https://www.quantisnow.com/insight/fractyl-health-to-participate-in-upcoming-investor-events-6645094)
- 2026-07-15 10:00 UTC [SEC Form 8-K] [Fractyl Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/fractyl-health-inc-filed-sec-form-8-k-regulation-fd-disclosure-6637428)
- 2026-07-15 10:00 UTC [Fractyl Health Reports Positive Randomized Data from REMAIN-1 Midpoint Cohort Demonstrating Durable Weight Maintenance One Year After GLP-1 Discontinuation](https://www.quantisnow.com/insight/fractyl-health-reports-positive-randomized-data-from-remain-1-midpoint-cohort-6637368)
- 2026-06-15 22:06 UTC [Insider Buy] [Director Royan Ajay bought $19,596 worth of shares (23,000 units at $0.85), increasing direct ownership by 128% to 40,901 units (SEC Form 4)](https://www.quantisnow.com/insight/director-royan-ajay-bought-19596-worth-of-shares-23000-units-6603381)
- 2026-06-11 21:15 UTC [SEC Form 8-K] [Fractyl Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders](https://www.quantisnow.com/insight/fractyl-health-inc-filed-sec-form-8-k-submission-of-matters-6599058)
- 2026-06-11 20:59 UTC [Insider Buy] [Chief Executive Officer Rajagopalan Harith bought $18,252 worth of shares (25,000 units at $0.73), increasing direct ownership by 5% to 540,557 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-rajagopalan-harith-bought-18252-worth-of-shares-6598934)
- 2026-06-11 21:00 UTC [Insider Buy] [Director Sheffield Ian bought $25,529 worth of shares (35,000 units at $0.73) (SEC Form 4)](https://www.quantisnow.com/insight/director-sheffield-ian-bought-25529-worth-of-shares-35000-units-6598889)
- 2026-06-11 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Director Meanwell Clive](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-meanwell-clive-6598884)
- 2026-06-11 21:02 UTC [SEC Form 4] [SEC Form 4 filed by Director Barnes Kelly Ann](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-barnes-kelly-ann-6598874)
- 2026-06-11 21:02 UTC [SEC Form 4] [SEC Form 4 filed by Director Elia Marc](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-elia-marc-6598873)
- 2026-06-11 21:02 UTC [SEC Form 4] [SEC Form 4 filed by Director Thompson Christopher Charles](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-thompson-christopher-charles-6598870)
- 2026-06-11 21:03 UTC [SEC Form 4] [SEC Form 4 filed by Director Royan Ajay](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-royan-ajay-6598869)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/GUTS
- Earnings history: https://www.quantisnow.com/earnings/GUTS
- Dividend history: https://www.quantisnow.com/dividends/GUTS
- Insider transactions: https://www.quantisnow.com/insiders/GUTS
- Options chain: https://www.quantisnow.com/options/GUTS
- SEC 8-K filings only: https://www.quantisnow.com/company/GUTS/8-k
- RSS and alerts for GUTS: https://www.quantisnow.com/docs/rss-feeds.md
